Regeneron is much greater than this Covid-19 story: Analyst

Regeneron's stock is up after it requested FDA emergency use approval for its antibody treatment. Alethia Young, Cantor Fitzgerald, joins 'Closing Bell' to discuss why she upgraded Regeneron's stock from overweight to neutral.
03:47
Thu, Oct 8 20203:31 PM EDT